Bond Biosciences, Inc.
5 private offerings reported to the SEC on Form D since 2016, $24.1M sold in all. Other health care, Missouri.
- Form D offerings: 5
- Reported sold: $24.1M
- Newest: Apr 8, 2026
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Apr 8, 2026 | — | $7.6M | $15.0M | Bond Biosciences, Inc.Other health care · Missouri | Oct 5, 2026 | 0001014108-26-000021 |
| Sep 6, 2024 | — | $4.5M | $4.5M | Bond Biosciences, Inc.Other health care · Missouri | Jan 29, 2026 | 0001014108-24-000040 |
| Jan 3, 2022 | — | $6.8M | $10.0M | Bond Biosciences, Inc.Other health care · New York | Not amended | 0001014108-21-000224 |
| Nov 4, 2020 | — | $5.0M | $6.0M | Bond Biosciences, Inc.Other health care · New York | Dec 8, 2020 | 0001014108-20-000122 |
| Sep 14, 2020 | — | $200K | $200K | Bond Biosciences, Inc.Other health care · New York | Not amended | 0001014108-20-000108 |
- Business address
- New York, NY
- Incorporated in
- Delaware
- All SEC filings
- CIK 1824224 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR